or Try an Advanced Search...

    Technical Analysis for HLS - HLS Therapeutics Inc

    Grade Last Price % Change Price Change
    B 4.750 0.00% 0.000
    HLS closed unchanged on Tuesday, April 23, 2024, on 18 percent of normal volume.
    Earnings due: May 9
    *** please verify all earnings dates ***
    0 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Up Up Down
    Historical HLS trend table...
    Date Alert Name Type % Chg
    MACD Bearish Signal Line Cross Bearish 0.00%
    Narrow Range Bar Range Contraction 0.00%
    Inside Day Range Contraction 0.00%
    Wide Bands Range Expansion 0.00%
    200 DMA Support Bullish 0.00%
    Wide Bands Range Expansion 0.00%
    NR7 Range Contraction -4.04%
    NR7-2 Range Contraction -4.04%
    Narrow Range Bar Range Contraction -4.04%
    Wide Bands Range Expansion -4.04%
    Older End-of-Day Signals for HLS ...

       Recent Intraday Alerts

    Alert Time
    Possible Inside Day about 20 hours ago
    200 DMA Support 2 days ago
    Down 1 ATR 2 days ago
    Fell Below Previous Day's Low 2 days ago
    Down 5% 2 days ago
    View Earlier Intraday Alerts

    Get a Trading Sidekick!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Get Started for Free!
    Configure default chart indicators
    HLS Chart by TradingView
    Basic chart:

    Profile

    HLS Therapeutics Inc., a specialty pharmaceutical company, acquires and commercializes pharmaceutical products in the specialty central nervous system and cardiovascular markets in Canada, the United States, and internationally. Its lead product is Clozaril, an atypical antipsychotic used in the treatment of schizophrenia. The company also holds the U.S. marketing rights of Absorica, a commercial stage dermatology product. HLS Therapeutics Inc. has a license agreement with Amarin Corporation plc to register, commercialize, and distribute Vascepa capsules in Canada. The company was founded in 2018 and is headquartered in Toronto, Canada.
    Classification
    Sector: Healthcare
    Industry: Drug Manufacturers - Specialty & Generic
    Keywords: Pharmaceutical Life Sciences Pharmaceutical Products Schizophrenia

    Is HLS a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 4 bullish, 0 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 7.12
    52 Week Low 3.34
    Average Volume 11,256
    200-Day Moving Average 4.679
    50-Day Moving Average 4.262
    20-Day Moving Average 4.527
    10-Day Moving Average 4.950
    Average True Range 0.212
    RSI (14) 56.52
    ADX 40.15
    +DI 40.124
    -DI 21.886
    Chandelier Exit (Long, 3 ATRs) 4.845
    Chandelier Exit (Short, 3 ATRs) 4.155
    Upper Bollinger Bands 5.585
    Lower Bollinger Band 3.469
    Percent B (%b) 0.61
    BandWidth 46.724
    MACD Line 0.217
    MACD Signal Line 0.218
    MACD Histogram -0.0006
    Fundamentals Value
    Market Cap 151.16 Million
    Num Shares 31.8 Million
    EPS -0.90
    Price-to-Earnings (P/E) Ratio -5.29
    Price-to-Sales 8.55
    Price-to-Book 2.89
    Dividend 0.16
    Dividend Yield 3.37%
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 4.750
    Resistance 3 (R3) 4.750 4.750 4.750
    Resistance 2 (R2) 4.750 4.750 4.750 4.750
    Resistance 1 (R1) 4.750 4.750 4.750 4.750 4.750
    Pivot Point 4.750 4.750 4.750 4.750 4.750
    Support 1 (S1) 4.750 4.750 4.750 4.750 4.750
    Support 2 (S2) 4.750 4.750 4.750 4.750
    Support 3 (S3) 4.750 4.750 4.750
    Support 4 (S4) 4.750